Recently, the reporter learned from the city's health and family planning system meeting that Shanghai issued a “1+7†document on drug product rebates, strengthened the construction of drug product rebate management system, and resolutely rectified the industry's unhealthy trends in drug purchase and sales and medical services.
The “1+7†document thoroughly investigated and researched the key areas and key links of institutions, personnel, places, behaviors, processes, etc. involved in medical product rebates, and combed relevant policies and regulations, and followed “targeted, specific, and operableâ€. The principle of "recourse to the responsibility" has formed a "combination boxing" document for the reinstatement of pharmaceutical products.
In the improvement of drug selection, it is required to standardize the drug operation process and refine the responsibility for drug management supervision. Focus on strengthening the centralized and unified supervision functions of drug selection, procurement, and use. For the newly applied drugs, the clinical departments will discuss and evaluate, and the pharmaceutical department will conduct a preliminary preliminary examination, and compare and analyze the newly applied drugs with the existing similar and same varieties. The meeting will vote by secret ballot to ensure that the selection of drugs is in order.
Strengthen prescription management, standardize physician prescription behavior, and further promote clinical rational drug use. Strengthen the hospital prescription review, including the national basic drugs, blood products, Chinese medicine injections, parenteral nutrition preparations, antibacterial drugs, adjuvant treatment drugs, hormones, high-cost self-funded drugs and other clinical use. Dynamic monitoring is implemented. The number and amount of drugs used in a single variety are sorted according to the clinical department and physicians, and the drugs with abnormal growth or ranking are monitored and evaluated. Strengthen the application of prescription review results, regularly publish the results of prescription reviews, register and report unreasonable prescriptions, and intervene in time for irrational use of drugs; implement interventions such as purchase restriction and suspension of procurement for drugs with abnormal growth in usage. Medical institutions that do not follow the prescribed prescriptions and have not established a sound system shall be ordered to correct and report criticism, and warned or recorded the punishment of the responsible personnel. For doctors who have unreasonable prescriptions, they should take measures such as education, training, criticism, etc., and be linked to the regular assessment of doctors. If the circumstances are serious, their prescription rights will be cancelled. At the same time, establish an irrational drug interview system, and treat the doctors who have verified the violations in accordance with the medical insurance and health regulations.
Formulate the hospitality management system for pharmaceutical production and operation enterprises in medical institutions, establish "segregation measures" through the combination of human defense technology and prevention, establish a system for issuing and issuing certificates for pharmaceutical production and operation enterprises and their agents, and set time, place, personnel, and records. In the case of “internal reception process, pharmaceutical production and operation enterprises and their agents must present their credentials to enter the medical institution to carry out their work, and it is strictly forbidden to carry out activities other than academic promotion and technical consultation. The pharmaceutical production and operation enterprises that violate the regulations are given the treatment of stopping the purchase of products.
At the same time, the city will also implement a record of commercial bribery in the field of pharmaceutical purchases and sales, and expressly prohibit commercial bribery in various nominal and formal forms that may occur in the purchase and sale of pharmaceutical products and medical activities. Clearly handle the handling of pharmaceutical production and operation enterprises and their agents who implement commercial bribery. The punishment measures are linked to the centralized procurement qualification of pharmaceutical products in this Municipality. Once there is commercial bribery, they shall not participate in centralized procurement within 2 years, and medical and health institutions may not purchase or use them. The enterprise product.
Pharmaceuticals finish product is the main product of Ningbo Voice Biochemic Co., Ltd.. The product line covers almost all the dosage forms, including tablets, capsules, small volume injections, infusions, eye/ear drops, creams and ointments, powder for injections and Aerosols. All finish products are produced in the GMP standard workshop.
Our
pharmaceutical finish products are registered in the countries of Asia,
Africa and South America under our own brand: VOICE, which is have won a
high reputation in the marketing countries. Together with our own trade
mark, the packaging of all pharmaceuticals finish products are well
designed according to the requirement of different market..
Cardiovascular Drugs,Antipyretic Analgesics,Antiviral And Antibiotics,Finished Pharmaceutical Products
NINGBO VOICE BIOCHEMIC CO. LTD , https://www.medicine-voice.com